Study S002344

Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00579150
Acronym: Exenatide
Study type: OBSERVATIONAL
Status: TERMINATED
Enrollment: 7
Start: 2009-01
Primary completion: 2016-04
Lead sponsor: AstraZeneca
Conditions: Birth Defects; Type 2 Diabetes; Preterm Birth
Results posted: FALSE
Secondary identifiers: OTHER:BCA401

Registered primary outcomes

Primary Outcome [For each group, primary outcome measure will be assessed among all births, including major birth defects identified during the postnatal period and up to infant age 12 months.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.